Niche focus Target gene therapy opportunities using AAV-based directed evolution to address chronic or debilitating diseases, aligning sales efforts with potential mid to late-stage programs seeking durable protein expression.

Early-stage leverage Engage Adverum as a partner for early feasibility studies or platform validation to de-risk pipeline concepts before larger collaborations, given their specialized AAV platform and compact team size.

Strategic partnerships Position collaborative models such as co-development, research-only, or access to platform capabilities to accelerate candidate generation, leveraging their focus on durable therapeutic expression.

Resource alignment Offer service packages scaled to small biotech profiles, including rapid prototyping, help with vector design, and preclinical feasibility, suitable for a company with a lean headcount and modest revenue.

Market readiness Highlight opportunities for supporting translational activities, regulatory readiness, and manufacturing scale-up collaborations to support eventual commercialization as programs advance.